Copy of Developing an assay to measure neuron-to-neuron spread of α-synuclein pathology on a microfluidics platform

Project Details

StatusFinished
Effective start/end date1/12/21 → 30/11/22

Funding

  • Ucb Biopharma Srl: £24,298.06